These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36569848)

  • 1. A potential antibody repertoire diversification mechanism through tyrosine sulfation for biotherapeutics engineering and production.
    Zhong X; D'Antona AM
    Front Immunol; 2022; 13():1072702. PubMed ID: 36569848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine Sulfation at Antibody Light Chain CDR-1 Increases Binding Affinity and Neutralization Potency to Interleukine-4.
    D'Antona AM; Lee JM; Zhang M; Friedman C; He T; Mosyak L; Bennett E; Lin L; Silverman M; Cometa F; Meade C; Hageman T; Sousa E; Cohen J; Marquette K; Ferguson D; Zhong X
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repertoire Analysis of Antibody CDR-H3 Loops Suggests Affinity Maturation Does Not Typically Result in Rigidification.
    Jeliazkov JR; Sljoka A; Kuroda D; Tsuchimura N; Katoh N; Tsumoto K; Gray JJ
    Front Immunol; 2018; 9():413. PubMed ID: 29545810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of the respective loops at complementarity determining region on the antigen-antibody recognition.
    Osajima T; Hoshino T
    Comput Biol Chem; 2016 Oct; 64():368-383. PubMed ID: 27591792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundamental characteristics of the expressed immunoglobulin VH and VL repertoire in different canine breeds in comparison with those of humans and mice.
    Steiniger SC; Dunkle WE; Bammert GF; Wilson TL; Krishnan A; Dunham SA; Ippolito GC; Bainbridge G
    Mol Immunol; 2014 May; 59(1):71-8. PubMed ID: 24509215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDR loop interactions can determine heavy and light chain pairing preferences in bispecific antibodies.
    Fernández-Quintero ML; Kroell KB; Grunewald LJ; Fischer AM; Riccabona JR; Liedl KR
    MAbs; 2022; 14(1):2024118. PubMed ID: 35090383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A window into the human immune system: comprehensive characterization of the complexity of antibody complementary-determining regions in functional antibodies.
    Mejias-Gomez O; Madsen AV; Skovgaard K; Pedersen LE; Morth JP; Jenkins TP; Kristensen P; Goletz S
    MAbs; 2023; 15(1):2268255. PubMed ID: 37876265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sequences encoded by immunoglobulin diversity (D
    Khass M; Vale AM; Burrows PD; Schroeder HW
    Immunol Rev; 2018 Jul; 284(1):106-119. PubMed ID: 29944758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures.
    Zemlin M; Klinger M; Link J; Zemlin C; Bauer K; Engler JA; Schroeder HW; Kirkham PM
    J Mol Biol; 2003 Dec; 334(4):733-49. PubMed ID: 14636599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor.
    Barrios Y; Jirholt P; Ohlin M
    J Mol Recognit; 2004; 17(4):332-8. PubMed ID: 15227640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDR-H3 diversity is not required for antigen recognition by synthetic antibodies.
    Persson H; Ye W; Wernimont A; Adams JJ; Koide A; Koide S; Lam R; Sidhu SS
    J Mol Biol; 2013 Feb; 425(4):803-11. PubMed ID: 23219464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De Novo Synthesis and Structural Elucidation of CDR-H3 Loop Mimics.
    Zhao G; Richaud AD; Williamson RT; Feig M; Roche SP
    ACS Chem Biol; 2024 Jul; 19(7):1583-1592. PubMed ID: 38916527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Unusual Genetics and Biochemistry of Bovine Immunoglobulins.
    Stanfield RL; Haakenson J; Deiss TC; Criscitiello MF; Wilson IA; Smider VV
    Adv Immunol; 2018; 137():135-164. PubMed ID: 29455846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (Glu62, Ala30, Tyr8)n serves as high-affinity substrate for tyrosylprotein sulfotransferase: a Golgi enzyme.
    Lee RW; Huttner WB
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6143-7. PubMed ID: 3862121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Despite extensive similarity in germline DH and JH sequence, the adult Rhesus macaque CDR-H3 repertoire differs from human.
    Link JM; Larson JE; Schroeder HW
    Mol Immunol; 2005 May; 42(8):943-55. PubMed ID: 15829286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of Framework Residue H71 Results in Different Antibody Paratope States in Solution.
    Fernández-Quintero ML; Kroell KB; Hofer F; Riccabona JR; Liedl KR
    Front Immunol; 2021; 12():630034. PubMed ID: 33737932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.
    De Pascalis R; Iwahashi M; Tamura M; Padlan EA; Gonzales NR; Santos AD; Giuliano M; Schuck P; Schlom J; Kashmiri SV
    J Immunol; 2002 Sep; 169(6):3076-84. PubMed ID: 12218124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and prediction of positional 4-hydroxyproline and sulfotyrosine, two post-translational modifications that can occur at substantial levels in CHO cells-expressed biotherapeutics.
    Tyshchuk O; Gstöttner C; Funk D; Nicolardi S; Frost S; Klostermann S; Becker T; Jolkver E; Schumacher F; Koller CF; Völger HR; Wuhrer M; Bulau P; Mølhøj M
    MAbs; 2019 Oct; 11(7):1219-1232. PubMed ID: 31339437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-in-one antibody engineered from a humanized interleukin 4 antibody through mutation in heavy chain complementarity-determining regions.
    Lee CV; Koenig P; Fuh G
    MAbs; 2014; 6(3):622-7. PubMed ID: 24618680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.